All Stories

  1. Efficacy of the digital therapeutic glucura combined with CGM in the treatment of type 2 diabetes: a randomised controlled trial over 6 months
  2. Updated Calibration Algorithm Improves Analytical Accuracy of a Continuous Glucose Monitoring System
  3. 10 years of the commission on laboratory diagnostics in diabetology: what has been achieved, and what’s next?
  4. Kontinuierliche Glukose- und Ketonmessung: Perspektiven für modernes Diabetesmanagement
  5. Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
  6. The Relevance of Error Grid Analysis in ISO 15197
  7. Definition, Classification, Diagnostics and Differential Diagnostics of Diabetes Mellitus: Update 2025
  8. Towards Standardization of CGM Performance Studies: The QUSS-CGM Questionnaire for Assessing User Satisfaction
  9. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2025
  10. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  11. Response to Comments on Freckmann et al. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. Diabetes Care 2025;48:1213–1217
  12. Discrepancies between current displayed and auto‐logged glucose values in FreeStyle Libre 3: Implications for clinical interpretation
  13. The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes
  14. Comparator Value Pairing Impacts Reported Continuous Glucose Monitoring System Accuracy
  15. Recommendations on the Collection of Comparator Measurement Data in the Performance Evaluation of Continuous Glucose Monitoring Systems
  16. Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM
  17. A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems
  18. Compliance With FDA iCGM Special Controls is Dependent on Study Design and Procedures
  19. Calibration and performance of a Raman-based device for non-invasive glucose monitoring in type 2 diabetes
  20. Feasibility of a Glucose Manipulation Procedure for the Standardized Performance Evaluation of Continuous Glucose Monitoring Systems
  21. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes
  22. Performance of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  23. The Need for Standardization of Continuous Glucose Monitoring Performance Evaluation: An Opinion by the International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Continuous Glucose Monitoring
  24. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2024
  25. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  26. Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings
  27. The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
  28. An SMS-Guided Basal Insulin Titration in People with Type 2 Diabetes New on Insulin
  29. Characteristics of Nocturnal Hypoglycaemic Events and Their Impact on Glycaemia
  30. Nocturnal Hypoglycemia in the Era of Continuous Glucose Monitoring
  31. Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes
  32. Unlocking Potential: Personalized Lifestyle Therapy for Type 2 Diabetes Through a Predictive Algorithm-Driven Digital Therapeutic
  33. Point-of-care testing: state-of-the art and perspectives
  34. Ein Pilotversuch zu Smartwatches mit Glukosemessfunktion
  35. Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems
  36. Effect of Arterialization on Venous Blood Glucose Concentrations and Implications for Observed Continuous Glucose Monitoring Accuracy
  37. Quality assessment of glucose measurement with regard to epidemiology and clinical management of diabetes mellitus in Germany
  38. Correction: Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  39. A Critical Discussion of Alert Evaluations in the Context of Continuous Glucose Monitoring System Performance
  40. Benefits of Usability Evaluation in the Development Process of Diabetes Technologies Using the Example of a Continuous Glucose Monitoring System Prototype
  41. A Proposal for the Clinical Characterization of Continuous Glucose Monitoring Trend Arrow Accuracy
  42. Even Head-to-Head Comparison Studies of Continuous Glucose Monitoring System Performance Can be Biased
  43. Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
  44. Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes
  45. Investigation of the Effect of 70 Potential Interferents on Measurement Results of Two Blood Glucose Monitoring Systems
  46. Are You Using the Recommended Test Tubes for Glucose Measurement? New Guidelines for Pre-analytical Handling in Germany
  47. Plasma Glucose Concentrations in Different Sampling Tubes Measured on Different Glucose Analysers
  48. Head-to-Head Evaluation of Continuous Glucose Monitoring and Automated Insulin Delivery Systems: Why are They not Used More Systematically?
  49. Evaluation of System Accuracy, Precision, Hematocrit Influence, and User Performance of Two Blood Glucose Monitoring Systems Based on ISO 15197:2013/EN ISO 15197:2015
  50. Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed Solutions
  51. Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial
  52. Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting
  53. Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung
  54. Kommentar zu den Konsequenzen aus der „Befragung zur Güte der Glukosemessung in niedergelassenen diabetologischen Praxen basierend auf einer Strukturbefragung“
  55. Comment on Hochfellner et al. Accuracy Assessment of the GlucoMen® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106
  56. Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump
  57. Differences in venous, capillary and interstitial glucose concentrations in individuals without diabetes after glucose load
  58. Glucose measurement and control in patients with type 1 or type 2 diabetes
  59. Automatisierte Insulindosierung: Ideale Diabeteskontrolle mit vielen offenen Fragen
  60. Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy
  61. A Statistical Approach for Assessing the Compliance of Integrated Continuous Glucose Monitoring Systems with Food and Drug Administration Accuracy Requirements
  62. Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
  63. Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial
  64. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  65. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results
  66. Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems
  67. Improving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration
  68. Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2022
  69. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  70. Suitability of continuous glucose monitoring in healthy subjects to detect effects of meal sequences and nutritional content of meals on postprandial glycemic responses
  71. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials
  72. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions
  73. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  74. Accuracy Evaluation of a Novel Reusable Patch Pump Prototype
  75. Patch Pumps: What are the advantages for people with diabetes?
  76. Patch Pumps: Periodic Insulin Delivery Patterns
  77. Definition, Classification and Diagnosis of Diabetes Mellitus
  78. Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus
  79. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  80. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  81. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
  82. Messqualität bei der Glukosemessung im Rahmen der Diabetesdiagnose und -therapie in Deutschland
  83. Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management
  84. Evaluation of the Accuracy and Reliability of a Tubeless Insulin Infusion System Under Laboratory Conditions
  85. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  86. Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis
  87. Correction to: Diabetes Technol Ther 2021;23(5):350−357
  88. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2021
  89. Response to Seibold: Data Obtained With Early Generations of CGM Sensors: Comment on Pleus et al.
  90. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany
  91. Glukosemessung in der Diabetesdiagnostik und -therapie: Laboratoriumsmedizinische Untersuchung inkl. patientennaher Sofortdiagnostik, Blutglukoseselbstmessung und kontinuierliches Glukosemonitoring
  92. Entwicklung und psychometrische Evaluation eines herstellerunabhängigen Wissenstests zum kontinuierlichen Glukosemonitoring in Echtzeit für insulinbehandelte Menschen mit Diabetes
  93. Development and Psychometric Assessment of a Manufacturer Independent Knowledge Questionnaire on Real Time Continuous Glucose Monitoring for insulin-treated People with Diabetes
  94. Comment on “Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory” by Spanou and Makris
  95. Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes
  96. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  97. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
  98. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study
  99. Standardization process of continuous glucose monitoring: Traceability and performance
  100. Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197
  101. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation
  102. Diabetesdiagnostik in der Hausarztpraxis
  103. Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“
  104. Variation of Mean Absolute Relative Differences of Continuous Glucose Monitoring Systems Throughout the Day
  105. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  106. Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials
  107. Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges
  108. Evaluation of the SPECTRUM training programme for real‐time continuous glucose monitoring: A real‐world multicentre prospective study in 120 adults with type 1 diabetes
  109. Diabetesdiagnostik in der Praxis
  110. Diabetesdiagnostik in der Hausarztpraxis
  111. Diagnostik des Gestationsdiabetes mellitus in der Praxis
  112. Stability of Glucose Concentrations in Frozen Plasma
  113. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control
  114. Definition, Klassifikation und Diagnostik des Diabetes mellitus: Update 2020
  115. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  116. Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline
  117. Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems
  118. Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring
  119. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  120. Der Auftragsverarbeitungsvertrag (AV-Vertrag): Relevanz und praktische Bedeutung für die Diabetologie
  121. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score
  122. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics
  123. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies
  124. Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management
  125. The YSI 2300 Analyzer Replacement Meeting Report
  126. Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose
  127. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
  128. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents
  129. Basics and use of continuous glucose monitoring (CGM) in diabetes therapy
  130. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015
  131. Simple Strategies for Retrospective Detection of Meals in Diabetes Datasets
  132. Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System
  133. Definition, Classification and Diagnosis of Diabetes Mellitus
  134. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes
  135. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
  136. Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature
  137. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  138. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  139. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia
  140. Concept and Implementation of a Novel Patch Pump for Insulin Delivery
  141. Untersuchung der Messgenauigkeit verschiedener Blutglukosemesssysteme, erworben in Discountern und Drogeriemärkten im Rahmen der Versorgungsforschung in Anlehnung an ISO 15197
  142. Feasibility of Fully Closed Loop Insulin Delivery in Type 2 Diabetes
  143. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  144. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space
  145. 119-LB: Bolus Dosing Accuracy of Two Recent Insulin Pumps
  146. 279-OR: How to Use rtCGM Data to Predict Future Severe Hypoglycemia?
  147. Advanced carbohydrate counting: An engineering perspective
  148. Deviation Analysis and Interval Modeling as Complementary Tools to Evaluate Insulin Dosing Algorithms in Diabetes
  149. Entwicklung und teststatistische Prüfung eines Wissenstests zum rtCGM (real-time continuous glucose monitoring): „rtCGM-Profi-Check“
  150. Genauigkeit verschiedener Insulinpumpen bei der Abgabe von Basalraten unter Verwendung eines typischen zirkadianen Profils mit zusätzlichen Bolusabgaben
  151. Kontinuierliches Glukosemonitoring bei Menschen ohne Diabetes nach vordefinierten Mahlzeiten und im Alltag
  152. Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems
  153. Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study
  154. Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements
  155. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  156. Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison
  157. The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study
  158. Comment on �accuracy and precision of four main glucometers used in a sub-Saharan African country: a cross-sectional study� by Choukem et al
  159. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  160. Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197
  161. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  162. Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices
  163. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
  164. Reporting Insulin Pump Accuracy: Trumpet Curves According to IEC 60601-2-24 and Beyond
  165. Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision
  166. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  167. Erratum: Definition, Klassifikation und Diagnostik des Diabetes mellitus
  168. Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  169. Correction: Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  170. Fallstricke bei der Diabetesdiagnostik: Wird zu lax mit Laborwerten umgegangen?
  171. Higher HbA1c Measurement Quality Standards are Needed for Follow-Up and Diagnosis: Experience and Analyses from Germany
  172. Patch Pumps: Are They All the Same?
  173. Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose MonitoringParts of the data have previously been presented at the 77th Scientific Sessions of the American Diabetes Association in San...
  174. Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring SystemsParts of these data were previously presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes, September 11–15, 2017, Lis...
  175. Accuracy of five systems for self-monitoring of blood glucose in the hands of adult lay-users and professionals applying ISO 15197:2013 accuracy criteria and potential insulin dosing errors
  176. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps
  177. First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
  178. Definition, Classification and Diagnosis of Diabetes Mellitus
  179. Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany
  180. Definition, classification and diagnostics of diabetes mellitus
  181. Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials
  182. Evaluation of Hematocrit Influence on Measurements With a Novel Self-Monitoring of Blood Glucose System Based on ISO 15197:2013
  183. Basal Rate Delivery of Different Insulin Pumps—An Accuracy Evaluation
  184. Delivery of Low Basal Rates in Different Insulin Pumps—An Accuracy Evaluation
  185. Predictors of Hypoglycemia Avoidance in a Randomized Controlled rtCGM Trial (HypoDE)
  186. The Relationship between A1C and Hypoglycemia in the HypoDE Study
  187. Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence
  188. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial
  189. User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors
  190. HbA1c-Messung in Deutschland: Ist die Qualität ausreichend für Verlaufskontrolle und Diagnose?
  191. Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published
  192. System Accuracy and User Performance Evaluation of an Improved System for Self-Monitoring of Blood Glucose
  193. Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?
  194. Identification of Mixed-Meal Effects on Insulin Needs and Glycemic Control
  195. Impact of Carbohydrate Counting Errors on Glycemic Control in Type 1 Diabetes
  196. People with Type 1 Diabetes and Increased Hypoglycemia Frequency have a Higher Risk for Nocturnal Hypoglycemia During the Second Half of the Night
  197. Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates
  198. HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle?
  199. Flash Glucose Monitoring: Differences Between Intermittently Scanned and Continuously Stored Data
  200. Definition, Klassifikation und Diagnostik des Diabetes mellitus
  201. Praxisempfehlung der DDG: Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes
  202. Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose With Three Test Strip Lots Based on ISO 15197:2013
  203. Comparative Handling Analysis of Different Insulin Pump Systems
  204. Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study
  205. ISO 15197: 2013 Evaluation of a Blood Glucose Monitoring System’s Measurement Accuracy
  206. Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors
  207. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View
  208. Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?
  209. Introduction of a Novel Smartphone-Coupled Blood Glucose Monitoring System
  210. Strengths and Limitations of New Approaches for Graphical Presentation of Blood Glucose Monitoring System Accuracy Data
  211. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements
  212. Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block
  213. Accuracy Assessment of an Improved Version of an Established Blood Glucose Monitoring System for Self-Testing Following ISO 15197:2013
  214. Continuous glucose monitoring: A training programme for all age groups
  215. Bolus Calculator Safety Mandates a Need for Standards
  216. Regulatorische Defizite bei Medizinprodukten
  217. Accuracy and user performance evaluation as key factors in self-monitoring in diabetes patients
  218. Significance and Reliability of MARD for the Accuracy of CGM Systems
  219. Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind
  220. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life
  221. Deviation analysis of clinical studies as tool to tune and assess performance of diabetes control algorithms
  222. SPECTRUM
  223. Boluses in Insulin Therapy
  224. Interferences and Limitations in Blood Glucose Self-Testing
  225. Comment on “The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System” by Bailey et al.
  226. Performance of two updated blood glucose monitoring systems: an evaluation following ISO 15197:2013
  227. Continuous Glucose Monitoring in 2015
  228. Self-Monitoring of Blood Glucose
  229. Identification of CGM Time Delays and Implications for BG Control in T1DM
  230. Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG
  231. Can We Use Measurements to Classify Patients Suffering from Type 1 Diabetes into Subcategories and Does It Make Sense?
  232. Accuracy of BG Meters and CGM Systems: Possible Influence Factors for the Glucose Prediction Based on Tissue Glucose Concentrations
  233. The Rectangle Target Plot
  234. Accuracy Evaluation of an Integrated Blood Glucose Monitoring System With Improved Test Cassettes Following ISO 15197:2013
  235. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing(POCT)-Blutglukose-Messsystemen mit Unit-use-Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestati...
  236. Updated Requirements for Measurement Quality and Quality Assurance of Point-Of-Care Testing (POCT) – Blood Glucose Measurement Systems with Unit-Use Reagents Suitable for the Initial Diagnosis of Diabetes Manifested in Pregnancy or Gestational Diabetes...
  237. CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring
  238. Performance Comparison of CGM Systems
  239. Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197
  240. System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods
  241. Time Delay of CGM Sensors
  242. Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View
  243. Identification of diurnal patterns in insulin action from measured CGM data for patients with T1DM
  244. Diagnostik des Gestationsdiabetes: Die Crux liegt bei der Blutentnahme
  245. ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose
  246. Neue Technologien in der Diabetologie
  247. System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method
  248. Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy
  249. Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings
  250. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS)
  251. Quality of HbA1c Measurement in the Practice
  252. Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing (POCT)-Blutglukose-Messsystemen mit Unit-use Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestat...
  253. Performance assessment of estimation methods for CIR/ISF in bolus calculators∗∗This work has been supported by the Linz Center of Mechatronics (LCM) in the framework of the Austrian COMET-K2 program
  254. LMI-based online estimation of a time-varying time-delay in continuous glucose measurement devices
  255. Use of Microdialysis-Based Continuous Glucose Monitoring to Drive Real-Time Semi-Closed-Loop Insulin Infusion
  256. Self-Monitoring of Blood Glucose
  257. Accuracy Assessment of an Advanced Blood Glucose Monitoring System for Self-Testing With Three Reagent System Lots Following ISO 15197:2013
  258. Model of the glucose-insulin system of type-1 diabetics and optimization-based bolus calculation
  259. Short-term prediction of blood glucose concentration using interval probabilistic models
  260. Accuracy Assessment of Two Novel Systems for Self-Monitoring of Blood Glucose Following ISO 15197:2013
  261. Accuracy Evaluation of Three Systems for Self-monitoring of Blood Glucose With Three Different Test Strip Lots Following ISO 15197
  262. Impact of Partial Pressure of Oxygen in Blood Samples on the Performance of Systems for Self-Monitoring of Blood Glucose
  263. Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility
  264. A-/B-Blutzuckermesssysteme
  265. Konsequenzen der Genauigkeit von Blutglucosemesssystemen
  266. Diabetestechnologie
  267. Auf dem Weg zum „Closed-loop“-System
  268. System accuracy evaluation of systems for point-of-care testing of blood glucose: a comparison of a patient-use system with six professional-use systems
  269. Influence of Partial Pressure of Oxygen in Blood Samples on Measurement Performance in Glucose-Oxidase-Based Systems for Self-Monitoring of Blood Glucose
  270. Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip
  271. In Response to Teodorczyk and Coauthors: System Accuracy of Blood Glucose Monitoring Devices According to the Current and Proposed ISO 15197 Standards
  272. Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms
  273. System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions
  274. Performance Evaluation of a Continuous Glucose Monitoring System under Conditions Similar to Daily Life
  275. Evaluation of the Performance of a Novel System for Continuous Glucose Monitoring
  276. Performance Evaluation of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors Per Subject in Parallel
  277. Effect of Infusion Rate and Indwelling Time on Tissue Resistance Pressure in Small-Volume Subcutaneous Infusion like in Continuous Subcutaneous Insulin Infusion
  278. Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union
  279. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use
  280. System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197
  281. Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197
  282. Increasing Local Blood Flow by Warming the Application Site: Beneficial Effects on Postprandial Glycemic Excursions
  283. Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements
  284. Integrated Self-Monitoring of Blood Glucose System: Handling Step Analysis
  285. Accuracy in Blood Glucose Measurement: What Will a Tightening of Requirements Yield?
  286. Clinical Performance of a Device That Applies Local Heat to the Insulin Infusion Site: A Crossover Study
  287. Blutzuckermessgeräte
  288. Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison
  289. System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
  290. Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII)
  291. Glucose monitoring by microdialysis: performance in a multicentre study
  292. The Clinical Research Tool: A High-Performance Microdialysis-Based System for Reliably Measuring Interstitial Fluid Glucose Concentration
  293. The Circadian Study:: The Get-Up Phenomenon in Type 1 Diabetes
  294. Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals
  295. Recent advances in continuous glucose monitoring